Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Perry

Showing results (451-460 of 628) with videos related to

Pageof 63
Sort By:
Neuro-Degenerative Diseases|March 7, 2008
Leucine-rich repeat kinase 2 colocalizes with alpha-synuclein in Parkinson's disease, but not tau-containing deposits in tauopathiesGeorge Perry, Xiongwei Zhu, Asim K Babar, et al.
Bioorganic & Medicinal Chemistry|November 17, 2024
Exploring the rhodanine universe: Design and synthesis of fluorescent rhodanine-based derivatives as anti-fibrillar and anti-oligomer agents against α-synuclein and 2N4R tauAhmed A Elbatrawy, Taiwo A Ademoye, Heba Alnakhala, et al.
ACS Omega|March 3, 2025
Inspecting the Triazole Scaffold as Powerful Antifibril Agents against 2N4R Tau and α-Synuclein AggregatesAhmed A Elbatrawy, Taiwo A Ademoye, Heba Alnakhala, et al.
Journal of Alzheimer'S Disease : JAD|July 12, 2005
What is aging? What is its role in Alzheimer's disease? What can we do about it?J Wesson Ashford, Craig S Atwood, John P Blass, et al.
Neurochemistry International|December 31, 2008
Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's diseaseHyoung-Gon Lee, Gemma Casadesus, Xiongwei Zhu, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer's Disease: Benefits and PitfallsPoul F Høilund-Carlsen, Mona-Elisabeth Revheim, Tommaso Costa, et al.
Aging Cell|July 14, 2016
Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau proteinGiusi Manassero, Michela Guglielmotto, Raluca Zamfir, et al.
Agro Food Industry Hi-Tech|May 6, 2011
Iron: A Pathological Mediator of Alzheimer Disease?Raj K Rolston, George Perry, Xiongwei Zhu, et al.
Acta Neurobiologiae Experimentalis|June 12, 2004
The role of metabotropic glutamate receptors in Alzheimer's diseaseHyoung-Gon Lee, Xiongwei Zhu, Michael J O'Neill, et al.
Trends in Molecular Medicine|April 13, 2005
Tau phosphorylation in Alzheimer's disease: pathogen or protector?Hyoung-Gon Lee, George Perry, Paula I Moreira, et al.
Pageof 63

Showing results (451-460 of 628) with videos related to

Sort By:
Pageof 63
Neuro-Degenerative Diseases|March 7, 2008
Leucine-rich repeat kinase 2 colocalizes with alpha-synuclein in Parkinson's disease, but not tau-containing deposits in tauopathiesGeorge Perry, Xiongwei Zhu, Asim K Babar, et al.
Bioorganic & Medicinal Chemistry|November 17, 2024
Exploring the rhodanine universe: Design and synthesis of fluorescent rhodanine-based derivatives as anti-fibrillar and anti-oligomer agents against α-synuclein and 2N4R tauAhmed A Elbatrawy, Taiwo A Ademoye, Heba Alnakhala, et al.
ACS Omega|March 3, 2025
Inspecting the Triazole Scaffold as Powerful Antifibril Agents against 2N4R Tau and α-Synuclein AggregatesAhmed A Elbatrawy, Taiwo A Ademoye, Heba Alnakhala, et al.
Journal of Alzheimer'S Disease : JAD|July 12, 2005
What is aging? What is its role in Alzheimer's disease? What can we do about it?J Wesson Ashford, Craig S Atwood, John P Blass, et al.
Neurochemistry International|December 31, 2008
Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's diseaseHyoung-Gon Lee, Gemma Casadesus, Xiongwei Zhu, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer's Disease: Benefits and PitfallsPoul F Høilund-Carlsen, Mona-Elisabeth Revheim, Tommaso Costa, et al.
Aging Cell|July 14, 2016
Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau proteinGiusi Manassero, Michela Guglielmotto, Raluca Zamfir, et al.
Agro Food Industry Hi-Tech|May 6, 2011
Iron: A Pathological Mediator of Alzheimer Disease?Raj K Rolston, George Perry, Xiongwei Zhu, et al.
Acta Neurobiologiae Experimentalis|June 12, 2004
The role of metabotropic glutamate receptors in Alzheimer's diseaseHyoung-Gon Lee, Xiongwei Zhu, Michael J O'Neill, et al.
Trends in Molecular Medicine|April 13, 2005
Tau phosphorylation in Alzheimer's disease: pathogen or protector?Hyoung-Gon Lee, George Perry, Paula I Moreira, et al.
Pageof 63